Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III Sells 3,000 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 3,000 shares of the firm’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of $45.63, for a total value of $136,890.00. Following the sale, the chief executive officer now directly owns 37,916 shares of the company’s stock, valued at approximately $1,730,107.08. This represents a 7.33 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The stock was sold at an average price of $48.53, for a total transaction of $10,336.89.
• On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44.
• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Trading Down 9.7 %

Shares of Kewaunee Scientific stock opened at $40.60 on Wednesday. The stock has a market capitalization of $115.91 million, a P/E ratio of 6.43 and a beta of 0.71. Kewaunee Scientific Co. has a 52-week low of $30.82 and a 52-week high of $71.33. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The stock’s 50-day simple moving average is $56.95 and its 200 day simple moving average is $47.55.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The company had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

Institutional Investors Weigh In On Kewaunee Scientific

Several institutional investors have recently made changes to their positions in KEQU. Minerva Advisors LLC raised its stake in shares of Kewaunee Scientific by 4.1% during the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock valued at $6,668,000 after purchasing an additional 4,311 shares during the period. Invesco Ltd. bought a new stake in shares of Kewaunee Scientific during the fourth quarter valued at about $6,545,000. De Lisle Partners LLP lifted its holdings in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Kewaunee Scientific by 18.0% in the fourth quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock valued at $2,122,000 after acquiring an additional 5,221 shares during the period. Finally, O Shaughnessy Asset Management LLC grew its stake in Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after acquiring an additional 891 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.